Drug Approval | July 03, 2022
Pfizer submits new drug application to the U.S. FDA for Paxlovid
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
Govt committed to supporting pharma companies with industry-friendly policies
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
Lacosamide Injection is used to treat partial-onset seizures.
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Subscribe To Our Newsletter & Stay Updated
